| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |